Category: Equity: Sectoral-Pharma and Healthcare |
Launch Date: 27-12-2024 |
Asset Class: |
Benchmark: BSE Healthcare TRI |
Expense Ratio: 2.37% As on ( 30-06-2025) |
Status: Open Ended Schemes |
Minimum Topup: 100.0 |
Total Assets: 332.33 Cr As on ( 30-06-2025) |
Turn over: |
FM 1 - Mr. Nimesh Chandan (Equity Portion) , FM 2 - Mr. Sorbh Gupta (Equity Portion) , FM-3- Mr. Siddharth Chaudhary (Debt Portion)
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.